TMPRSS2 and ovarian carcinoma: These results indicated that TMPRSS2 expression was decreased in many tumour tissues distinctively and was significantly related to the clinical outcomes in the brain, blood, colorectal, breast, lung, soft tissue and ovarian cancer.